Archive for September 2014
Anido Guides Aerie’s Push To Be A “Very Big Player” In Glaucoma
[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 009″] Vicente Anido, Jr., PhD’s career has taken him through large companies and private start-ups. He’s taken life science companies public on two occasions, and he’s seen nearly every perspective of the ophthalmology industry. Today, Anido expects big things for Aerie Pharmaceuticals, a clinical-stage pharmaceutical company with two promising treatments for…
Read MoreSlade Discusses The Opportunities, And Challenges, Of New Technology
[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 008″] Throughout his career, Stephen Slade, MD, has been an early adopter of new ophthalmic technologies, being among the first to use LASIK, and femtosecond lasers in cataract removal. As a seasoned early adopter, Slade expresses some reservations around new “back-office” technologies in his practice – namely EMRs. Despite these concerns,…
Read MoreOphthalmology Leaders Speak to Strength of Sector
A Wall Street Journal analysis of venture capital commitments showed ophthalmology remained the strongest sector within healthcare. According to the Wall Street Journal, privately held ophthalmology start-ups drew $442.7 million in capital over the first six months of this year, putting it on pace to surpass the $848.9 million raised in 2013. With the baby…
Read MoreHear How Avedro’s Muller Is Building A Cross-Linking Powerhouse
Episode 007 CEO David Muller, maps out Avedro’s designs to dominate the corneal cross-linking market and potentially change the game of vision correction. Podcast Guest David Muller, PhD Dr. Muller recognized the potential of using advanced methods to gently reshape the cornea and in 2007 founded Avedro, Inc., where he serves as the CEO. Under…
Read MoreKliman: Ophthalmology Is A “Leading Franchise” At InterWest
[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 006″] OIS Co-Chair, Gil Kliman, MD, Managing Director at InterWest Partners, delivers insight on his firm’s decision to concentrate on ophthalmology fifteen years ago and shares the many lessons he’s learned during that time. Podcast Guest Gilbert H. Kliman, MD Dr. Gil Kliman leads the medical device investment team at InterWest…
Read MoreAvedro Broadens Cross-Link Product Line
Corneal collagen cross-linking has been a vexing specialty for US-based companies trying to guide a product through a cautious FDA. But Massachusetts-based Avedro Inc., continues to establish a meaningful portfolio in the space through deals like the acquisition of Switzerland-based IROC Innocross AG. Avedro acquired the assets of IROC Innocross, which was the first company…
Read MoreLindstrom: Ophthalmologists Facing Both Opportunity & Pressure
[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 005″] Richard L. Lindstrom, MD, a long-time supporter of ophthalmology start-ups, looks ahead at the challenges facing physicians and investors as they work to meet the growing demand for ophthalmic treatment in an evolving healthcare industry. Podcast Guest Richard Lindstrom, MD Dr Richard L Lindstrom, Founder and attending surgeon at Minnesota…
Read MoreWaveTec “Must Have” for Alcon
WaveTec Vision Systems’ CEO, Tom Frinzi, delivered a bottom-line presentation at the Ophthalmology Innovation Summit @ASCRS in Boston. His six-minute presentation concentrated on the economic impact of WaveTec’s ORA System with VerifEye and concluded with this thought, “I would submit to you the ORA System with VerifEye is not a nice to have technology, it’s…
Read More